CSIMarket
 


Cvrx inc  (CVRX)
Other Ticker:  
 
 

CVRX's EPS Net Growth by Quarter and Year

Cvrx Inc's EPS Net results by quarter and year




CVRX EPS Net (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -0.44 -0.26 0.58 0.00
III Quarter September -0.43 -0.48 -48.48 0.00
II Quarter June -0.56 -0.49 0.00 0.00
I Quarter March -0.55 -0.49 0.00 0.00
FY   -1.98 -1.72 -47.90 0.00



CVRX EPS Net fourth quarter 2023 Y/Y Growth Comment
Cvrx inc in the fourth quarter 2023 recorded EPS net loss of $ -0.44 .

According to the results reported in the fourth quarter 2023, Cvrx Inc achieved the best EPS Net growth in Medical Equipment & Supplies industry. While Cvrx Inc' s EPS Net no change of % ranks overall at the positon no. in the fourth quarter 2023.




CVRX EPS Net ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Cvrx Inc's fourth quarter 2023 EPS Net $ -0.44 CVRX's Income Statement
Cvrx Inc's fourth quarter 2022 EPS Net $ -0.26 Quarterly CVRX's Income Statement
New: More CVRX's historic EPS Net Growth >>


CVRX EPS Net (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Cvrx Inc's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CVRX's IV. Quarter Q/Q EPS Net Comment
Current accomplishment of -0.44 by Cvrx inc come out even less good if you take a look at EPS net loss -0.43 a quarter before.

Within Medical Equipment & Supplies industry Cvrx inc achieved highest sequential EPS Net growth. While Cvrx Inc's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CVRX's IV. Quarter Q/Q EPS Net Comment
IV. Quarter 2023 accomplishment of -0.44 by Cvrx inc come out even less good considering the EPS net loss -0.43 in the third quarter.

Within Medical Equipment & Supplies industry Cvrx inc achieved highest sequential EPS Net growth. While Cvrx Inc's EPS Net growth quarter on quarter, overall rank is .


Cvrx Inc's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative EPS Net 12 Months Ending $ -1.98 $ -1.80 $ -1.85 $ -1.78 $ -1.72
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment
Cvrx Inc' has realized cumulative trailing twelve months EPS net loss of $ -2 in the Dec 31 2023 period.
The business is worsening as the cumulative EPS net loss is getting bigger from $ -1.8 for the period from Sep 30 2023 to Dec 31 2022 and $ -0.88215457033149 for the twelve months ending in the quarter Dec 31 2022 Alyssa A. Ramsey told.

Cvrx inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
Cvrx Inc' has realized cumulative trailing twelve months EPS net loss of $ -2 in the Dec 31 2023 period.
The results are worsening as the cumulative EPS net loss is inflating from $ -1.8 for the period from Sep 30 2023 to Dec 31 2022 and $ -0.88215457033149 from the TTM period ending Dec 31 2022.

Cvrx inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Medical Equipment & Supplies Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
CVRX's EPS Net Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for CVRX's Competitors
EPS Net Growth for Cvrx Inc's Suppliers
EPS Net Growth for CVRX's Customers

You may also want to know
CVRX's Annual Growth Rates CVRX's Profitability Ratios CVRX's Asset Turnover Ratio CVRX's Dividend Growth
CVRX's Roe CVRX's Valuation Ratios CVRX's Financial Strength Ratios CVRX's Dividend Payout Ratio
CVRX's Roa CVRX's Inventory Turnover Ratio CVRX's Growth Rates CVRX's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Dec 31 2023
Vericel Corporation117.26%$ 117.264 
Davita Inc 112.83%$ 112.825 
Iqvia Holdings Inc 110.58%$ 110.579 
Alpha Pro Tech Ltd 102.01%$ 102.011 
Stryker Corp101.49%$ 101.490 
Cytek Biosciences Inc 101.19%$ 101.187 
Corcept Therapeutics Inc93.66%$ 93.655 
Quest Diagnostics Inc91.92%$ 91.923 
Intuitive Surgical Inc 84.06%$ 84.063 
Astrazeneca Plc80.57%$ 80.569 
Cadre Holdings Inc 77.21%$ 77.209 
Dr Reddy s Laboratories Limited76.47%$ 76.471 
3m Company73.79%$ 73.795 
Electromed Inc 72.73%$ 72.727 
Select Medical Holdings Corp65.75%$ 65.751 
United Therapeutics Corporation63.06%$ 63.056 
Neurocrine Biosciences Inc 61.33%$ 61.332 
Halozyme Therapeutics Inc 55.17%$ 55.172 
Abbott Laboratories54.67%$ 54.667 
Lemaitre Vascular Inc 48.89%$ 48.895 
Msa Safety Incorporated45.39%$ 45.386 
Docgo Inc 45.08%$ 45.083 
Catalyst Pharmaceuticals Inc 41.53%$ 41.526 
Integer Holdings Corporation41.39%$ 41.393 
Healthcare Services Group Inc 40.63%$ 40.631 
Chemed Corporation40.08%$ 40.076 
Ufp Technologies Inc 37.57%$ 37.565 
Hologic Inc37.33%$ 37.333 
Baxter International Inc 34.83%$ 34.825 
West Pharmaceutical Services Inc 34.80%$ 34.797 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com